U.S. Food and Drug Administration''s Office of Orphan Products Development Issues Grant Supporting GenSperas Glioblastoma Study

SAN ANTONIO, TX -- (Marketwired) -- 06/17/15 -- (OTCQB: GNSZ) announced today that Santosh Kesari, MD, PhD, Principal Investigator of GenSpera''s glioblastoma clinical trial, received an RO-1 grant from the for ongoing mipsagargin clinical trial studies in humans. The clinical trial is being cond ...